{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:56:57Z","timestamp":1792796217328,"version":"4.5.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bcp.2020.114360","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T11:12:46Z","timestamp":1607339566000},"page":"114360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis"],"prefix":"10.1016","volume":"183","author":[{"given":"Yujing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.114360_b0005","doi-asserted-by":"crossref","unstructured":"J.S. Smolen et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the rheumatic diseases (2020) 79, 685-699, DOI:10.1136\/annrheumdis-2019-216655.","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"10.1016\/j.bcp.2020.114360_b0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.semarthrit.2019.02.004","article-title":"Risk profiling for a refractory course of rheumatoid arthritis","volume":"49","author":"B\u00e9c\u00e8de","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.bcp.2020.114360_b0015","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/annrheumdis-2018-214967","article-title":"Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts","volume":"78","author":"Sun","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2020.114360_b0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clim.2008.02.002","article-title":"Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb","volume":"127","author":"Magnusson","year":"2008","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"key":"10.1016\/j.bcp.2020.114360_b0025","first-page":"4552","article-title":"IgA complexes in plasma and synovial fluid of patients with rheumatoid arthritis induce neutrophil extracellular traps via Fc\u03b1RI","volume":"197","author":"Aleyd","year":"2016","journal-title":"J.I."},{"key":"10.1016\/j.bcp.2020.114360_b0030","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.0610852103","article-title":"Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1","volume":"104","author":"Nigrovic","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2020.114360_b0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/imr.12337","article-title":"The era of the immunoglobulin A Fc receptor Fc\u03b1RI; its function and potential as target in disease","volume":"268","author":"Aleyd","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bcp.2020.114360_b0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11418-014-0839-7","article-title":"Anethole and eugenol reduce in vitro and in vivo leukocyte migration induced by fMLP, LTB4, and carrageenan","volume":"68","author":"Estev\u00e3o-Silva","year":"2014","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bcp.2020.114360_b0045","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/eji.201646547","article-title":"The enigmatic function of IgD: some answers at last","volume":"48","author":"Gutzeit","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0050","doi-asserted-by":"crossref","unstructured":"Y. Wu et al. The Elevated Secreted Immunoglobulin D Enhanced the Activation of Peripheral Blood Mononuclear Cells in Rheumatoid Arthritis. PloS one (2016) 11, e0147788, DOI:10.1371\/journal.pone.0147788.","DOI":"10.1371\/journal.pone.0147788"},{"key":"10.1016\/j.bcp.2020.114360_b0055","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/aps.2017.105","article-title":"The immunoglobulin D Fc receptor expressed on fibroblast-like synoviocytes from patients with rheumatoid arthritis contributes to the cell activation","volume":"38","author":"Wu","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2020.114360_b0060","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ni.2939","article-title":"Type I and type II Fc receptors regulate innate and adaptive immunity","volume":"15","author":"Pincetic","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0065","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1073\/pnas.1307864110","article-title":"General mechanism for modulating immunoglobulin effector function","volume":"110","author":"Sondermann","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2020.114360_b0070","doi-asserted-by":"crossref","unstructured":"S. Bournazos, J.M. Woof, S.P. Hart, I. Dransfield. Functional and clinical consequences of Fc receptor polymorphic and copy number variants Clin Exp Immunol 157, 244-254, DOI:10.1111\/j.1365-2249.2009.03980.x (2009).","DOI":"10.1111\/j.1365-2249.2009.03980.x"},{"key":"10.1016\/j.bcp.2020.114360_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","article-title":"Fcgamma receptors: old friends and new family members","volume":"24","author":"Nimmerjahn","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2020.114360_b0080","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R","volume":"276","author":"Shields","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114360_b0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/35018508","article-title":"The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex","volume":"406","author":"Sondermann","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114360_b0090","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1016\/j.jmb.2014.07.006","article-title":"Structural characterization of anti-inflammatory immunoglobulin G Fc proteins","volume":"426","author":"Ahmed","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2020.114360_b0095","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin g subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114360_b0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fc\u03b3 receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/all.13635","article-title":"IgG4 drives M2a macrophages to a regulatory M2b-like phenotype: potential implication in immune tolerance","volume":"74","author":"Bianchini","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.bcp.2020.114360_b0115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1189\/jlb.1005586","article-title":"Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2)","volume":"80","author":"Sironi","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2020.114360_b0120","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4161\/19420862.2014.975657","article-title":"IgG4 can induce an M2-like phenotype in human monocyte-derived macrophages through Fc\u03b3RI","volume":"6","author":"Swisher","year":"2014","journal-title":"mAbs"},{"key":"10.1016\/j.bcp.2020.114360_b0125","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20062545","article-title":"Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program","volume":"204","author":"Dhodapkar","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2020.114360_b0130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fimmu.2017.00280","article-title":"Fc\u03b3 receptor heterogeneity in leukocyte functional responses","volume":"8","author":"Rosales","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaut.2012.12.002","article-title":"FcR\u03b3 promotes T cell apoptosis in Fas-deficient mice","volume":"42","author":"Juvet","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bcp.2020.114360_b0140","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood.V90.3.1267","article-title":"Fc gammaRII (CD32) is linked to apoptotic pathways in murine granulocyte precursors and mature eosinophils","volume":"90","author":"de Andr\u00e9s","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2020.114360_b0145","doi-asserted-by":"crossref","unstructured":"T.A. Hamdan, P.A. Lang, K.S. Lang. The Diverse Functions of the Ubiquitous Fc\u03b3 Receptors and Their Unique Constituent, FcR\u03b3 Subunit Pathogens 9 DOI:10.3390\/pathogens9020140.","DOI":"10.3390\/pathogens9020140"},{"key":"10.1016\/j.bcp.2020.114360_b0150","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1189\/jlb.70.4.649","article-title":"Phosphatidylinositol 3-kinase and ERK are required for NF-kappaB activation but not for phagocytosis","volume":"70","author":"Garc\u00eda-Garc\u00eda","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2020.114360_b0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/368070a0","article-title":"A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling","volume":"368","author":"Muta","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114360_b0160","doi-asserted-by":"crossref","unstructured":"O. Malbec et al. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation. Journal of immunology (Baltimore, Md. : 1950) 160, 1647-1658 (1998).","DOI":"10.4049\/jimmunol.160.4.1647"},{"key":"10.1016\/j.bcp.2020.114360_b0165","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3389\/fimmu.2019.00811","article-title":"Understanding Fc receptor involvement in inflammatory diseases: from mechanisms to new therapeutic tools","volume":"10","author":"Ben Mkaddem","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0065-2776(08)60019-X","article-title":"Inhibitory pathways triggered by ITIM-containing receptors","volume":"72","author":"Bolland","year":"1999","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0175","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1101\/gad.14.5.505","article-title":"Structure, function, and biology of SHIP proteins","volume":"14","author":"Rohrschneider","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2020.114360_b0180","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1172\/JCI74572","article-title":"Shifting Fc\u03b3RIIA-ITAM from activation to inhibitory configuration ameliorates arthritis","volume":"124","author":"Ben Mkaddem","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2020.114360_b0185","doi-asserted-by":"crossref","unstructured":"M.J. Zhou, E.J. Brown. CR3 (Mac-1, alpha M beta 2, CD11b\/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst: requirement for Fc gamma RIII and tyrosine phosphorylation J Cell Biol 125 (1994) 1407\u20131416 DOI:10.1083\/jcb.125.6.1407.","DOI":"10.1083\/jcb.125.6.1407"},{"key":"10.1016\/j.bcp.2020.114360_b0190","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.drudis.2014.03.028","article-title":"Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis","volume":"19","author":"Whang","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2020.114360_b0195","first-page":"303","article-title":"Bridging autoantibodies and arthritis: the role of Fc receptors","volume":"382","author":"el Bannoudi","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0200","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar3237","article-title":"Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis","volume":"13","author":"Kokkonen","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2020.114360_b0205","doi-asserted-by":"crossref","unstructured":"A.-M. Quirke, B.A.C. Fisher, A.J. Kinloch, P.J. Venables. Citrullination of autoantigens: Upstream of TNF\u03b1 in the pathogenesis of rheumatoid arthritis FEBS Lett 585, 3681-3688 DOI:10.1016\/j.febslet.2011.06.006.","DOI":"10.1016\/j.febslet.2011.06.006"},{"key":"10.1016\/j.bcp.2020.114360_b0210","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1002\/art.20672","article-title":"A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis","volume":"50","author":"Wijngaarden","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2020.114360_b0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2015.00079","article-title":"Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity","volume":"6","author":"Vogelpoel","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0220","doi-asserted-by":"crossref","unstructured":"I. Di Ceglie, N.N.L. Kruisbergen, M.H.J. van den Bosch, P.L.E.M. van Lent. Fc-gamma receptors and S100A8\/A9 cause bone erosion during rheumatoid arthritis. Do they act as partners in crime? Rheumatology (Oxford, England) 58 (2019) 1331\u20131343 DOI:10.1093\/rheumatology\/kez218.","DOI":"10.1093\/rheumatology\/kez218"},{"key":"10.1016\/j.bcp.2020.114360_b0225","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1172\/JCI24772","article-title":"Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions","volume":"115","author":"Boruchov","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bcp.2020.114360_b0230","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1084\/jem.191.9.1611","article-title":"Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors","volume":"191","author":"Kleinau","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2020.114360_b0235","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/1529-0131(200004)43:4<740::AID-ANR4>3.0.CO;2-0","article-title":"Role of Fc receptor gamma chain in inflammation and cartilage damage during experimental antigen-induced arthritis","volume":"43","author":"van Lent","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2020.114360_b0240","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1002\/1521-4141(2002010)32:10<2915::AID-IMMU2915>3.0.CO;2-4","article-title":"Expression of FcgammaRIII is required for development of collagen-induced arthritis","volume":"32","author":"D\u00edaz de St\u00e5hl","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0245","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1074-7613(02)00294-7","article-title":"FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection","volume":"16","author":"Ioan-Facsinay","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2020.114360_b0250","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1002\/art.21344","article-title":"Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice","volume":"52","author":"Tan Sardjono","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2020.114360_b0255","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.23284","article-title":"Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen","volume":"58","author":"Clavel","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2020.114360_b0260","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/ard.2010.142091","article-title":"Fc\u03b3 receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins","volume":"70","author":"Laurent","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2020.114360_b0265","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.30081","article-title":"Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fc\u03b3 receptor","volume":"63","author":"Sokolove","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2020.114360_b0270","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6444","article-title":"Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages","volume":"5","author":"Vogelpoel","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2020.114360_b0275","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/ard.2006.068981","article-title":"Treatment of lupus-prone NZB\/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32)","volume":"67","author":"Werwitzke","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2020.114360_b0280","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/art.1780401117","article-title":"In vitro induction of proinflammatory cytokine secretion by juvenile rheumatoid arthritis synovial fluid immune complexes","volume":"40","author":"Jarvis","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2020.114360_b0285","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ncprheum0020","article-title":"Cytokine networks\u2014towards new therapies for rheumatoid arthritis","volume":"1","author":"McInnes","year":"2005","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2020.114360_b0290","doi-asserted-by":"crossref","unstructured":"J.L. EllsworthiRecombinant soluble human FcgammaR1A (CD64A) reduces inflammation in murine collagen-induced arthritis. Journal of immunology (Baltimore, Md. : 1950) 182, 7272-7279, DOI:10.4049\/jimmunol.0803497 (2009).","DOI":"10.4049\/jimmunol.0803497"},{"key":"10.1016\/j.bcp.2020.114360_b0295","doi-asserted-by":"crossref","unstructured":"J.L. Ellsworth et al. Targeting immune complex-mediated hypersensitivity with recombinant soluble human FcgammaRIA (CD64A). Journal of immunology (Baltimore, Md. : 1950) 180, 580-589, DOI:10.4049\/jimmunol.180.1.580 (2008).","DOI":"10.4049\/jimmunol.180.1.580"},{"key":"10.1016\/j.bcp.2020.114360_b0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2013.12.014","article-title":"Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis","volume":"52","author":"Thiruppathi","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bcp.2020.114360_b0305","doi-asserted-by":"crossref","first-page":"R192","DOI":"10.1186\/ar4024","article-title":"Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice","volume":"14","author":"Jain","year":"2012","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.bcp.2020.114360_b0310","doi-asserted-by":"crossref","unstructured":"X. Zhang et al. A recombinant human IgG1 Fc multimer designed to mimic the active fraction of IVIG in autoimmunity JCI insight 4, e121905 DOI:10.1172\/jci.insight.121905DS1.","DOI":"10.1172\/jci.insight.121905"},{"key":"10.1016\/j.bcp.2020.114360_b0315","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf9418","article-title":"Elucidating the interplay between IgG-Fc valency and Fc\u03b3R activation for the design of immune complex inhibitors","volume":"8","author":"Ortiz","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2020.114360_b0320","doi-asserted-by":"crossref","first-page":"102366","DOI":"10.1016\/j.autrev.2019.102366","article-title":"Next-generation Fc receptor\u2013targeting biologics for autoimmune diseases","volume":"18","author":"Zuercher","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bcp.2020.114360_b0325","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/annrheumdis-2018-213523","article-title":"Humanised effector-null Fc\u03b3RIIA antibody inhibits immune complex-mediated proinflammatory responses","volume":"78","author":"Chen","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2020.114360_b0330","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/art.38334","article-title":"suppression of rheumatoid arthritis B cells by XmAb5871, an Anti-CD19 antibody that coengages B Cell antigen receptor complex and Fc\u03b3 receptor IIb inhibitory receptor: suppression of RA B cells by coengagement of Fc\u03b3RIIb and CD19","volume":"66","author":"Chu","year":"2014","journal-title":"Arthrit. Rheumatol."},{"key":"10.1016\/j.bcp.2020.114360_b0335","doi-asserted-by":"crossref","unstructured":"M. Oll\u00e9. The European League Against Rheumatism (EULAR) - 16th Annual European Congress (June 10-13, 2015 - Rome, Italy). Drugs of today (Barcelona, Spain : 1998) 51, 387-392, DOI:10.1358\/dot.2015.51.6.2358889 (2015).","DOI":"10.1358\/dot.2015.51.6.2358889"},{"key":"10.1016\/j.bcp.2020.114360_b0340","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0955-0674(00)00120-4","article-title":"Membrane traffic in polarized epithelial cells","volume":"12","author":"Mostov","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bcp.2020.114360_b0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev.iy.12.040194.000431","article-title":"Transepithelial transport of immunoglobulins","volume":"12","author":"Mostov","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0350","doi-asserted-by":"crossref","unstructured":"R.C. Monteiro, H. Kubagawa, M.D. Cooper. Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans. J Exp Med 171 (1990) 597\u2013613 DOI:10.1084\/jem.171.3.597.","DOI":"10.1084\/jem.171.3.597"},{"key":"10.1016\/j.bcp.2020.114360_b0355","doi-asserted-by":"crossref","unstructured":"C.R. Maliszewski, C.J. March, M.A. Schoenborn, S. Gimpel, L. Shen. Expression cloning of a human Fc receptor for IgA. J Exp Med 172 (1990) 1665\u20131672 DOI:10.1084\/jem.172.6.1665.","DOI":"10.1084\/jem.172.6.1665"},{"key":"10.1016\/j.bcp.2020.114360_b0360","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/80886","article-title":"Fc alpha\/mu receptor mediates endocytosis of IgM-coated microbes","volume":"1","author":"Shibuya","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0365","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1073\/pnas.79.20.6229","article-title":"IgA interaction with the asialoglycoprotein receptor.","volume":"79","author":"Stockert","year":"1982","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2020.114360_b0370","doi-asserted-by":"crossref","unstructured":"I.C. Moura et al. Identification of the Transferrin Receptor as a Novel Immunoglobulin (Ig)a1 Receptor and Its Enhanced Expression on Mesangial Cells in Iga Nephropathy J Exp Med 194 (2001) 417\u2013426 DOI:10.1084\/jem.194.4.417.","DOI":"10.1084\/jem.194.4.417"},{"key":"10.1016\/j.bcp.2020.114360_b0375","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00018-018-2976-8","article-title":"The inflammatory function of human IgA","volume":"76","author":"Hansen","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2020.114360_b0380","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/76261","article-title":"FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity","volume":"6","author":"van Egmond","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2020.114360_b0385","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1189\/jlb.0508327","article-title":"Functional expression of IgA receptor FcalphaRI on human platelets","volume":"84","author":"Qian","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2020.114360_b0390","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1073\/pnas.1914186117","article-title":"IL-4 controls activated neutrophil Fc\u03b3R2b expression and migration into inflamed joints","volume":"117","author":"Panda","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2020.114360_b0395","first-page":"2374","article-title":"IgA enhances NETosis and release of neutrophil extracellular traps by polymorphonuclear cells via Fc\u03b1 receptor I","volume":"192","author":"Aleyd","year":"2014","journal-title":"J.I."},{"key":"10.1016\/j.bcp.2020.114360_b0400","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.4049\/jimmunol.174.9.5472","article-title":"Immature neutrophils mediate tumor cell killing via IgA but Not IgG Fc receptors","volume":"174","author":"Otten","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0405","first-page":"303","article-title":"IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes","volume":"61","author":"Gorter","year":"1987","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2020.114360_b0410","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.06.047","article-title":"Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4","volume":"137","author":"van der Steen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2020.114360_b0415","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.V97.1.205","article-title":"Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor is enhanced through Fc receptor gamma-chain signaling","volume":"97","author":"Shen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2020.114360_b0420","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/332647a0","article-title":"GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism","volume":"332","author":"Weisbart","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114360_b0425","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mi.2011.36","article-title":"The human immunoglobulin A Fc receptor Fc\u03b1RI: a multifaceted regulator of mucosal immunity","volume":"4","author":"Bakema","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0430","first-page":"5649","article-title":"Human IgA Fc Receptor Fc\u03b1RI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironment","volume":"193","author":"Wehrli","year":"2014","journal-title":"J.I."},{"key":"10.1016\/j.bcp.2020.114360_b0435","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.immunol.21.120601.141011","article-title":"IgA Fc receptors","volume":"21","author":"Monteiro","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0440","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03318-5","article-title":"Fc\u03b1RI co-stimulation converts human intestinal CD103+ dendritic cells into pro-inflammatory cells through glycolytic reprogramming","volume":"9","author":"Hansen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2020.114360_b0445","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.smim.2016.02.004","article-title":"Immunoreceptors on neutrophils","volume":"28","author":"van Rees","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0450","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.autrev.2012.10.011","article-title":"Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives","volume":"12","author":"Ben Mkaddem","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bcp.2020.114360_b0455","first-page":"31","article-title":"Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM","volume":"22","author":"Pasquier","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2020.114360_b0460","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001309","article-title":"Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized \u201cinhibisome\u201d clusters","volume":"4","author":"Pfirsch-Maisonnas","year":"2011","journal-title":"Sci. Signaling"},{"key":"10.1016\/j.bcp.2020.114360_b0465","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1196\/annals.1398.034","article-title":"Predictive value of antibodies to citrullinated peptides and rheumatoid factors in anti-TNF-alpha treated patients","volume":"1109","author":"Bobbio-Pallavicini","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2020.114360_b0470","first-page":"823","article-title":"The association of immunoglobulin A, immunoglobulin G and anti-cyclic citrullinated peptide antibodies with disease activity in seronegative rheumatoid arthritis patients","volume":"19","author":"Karimifar","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.bcp.2020.114360_b0475","first-page":"3664","article-title":"IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor\u2013 and complement-dependent effector functions of the disease-specific anti\u2013citrullinated protein autoantibodies","volume":"194","author":"Anquetil","year":"2015","journal-title":"J.I."},{"key":"10.1016\/j.bcp.2020.114360_b0480","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in rheumatoid arthritis","volume":"118","author":"Brennan","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2020.114360_b0485","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/art.23597","article-title":"CXCR2\u2010specific chemokines mediate leukotriene B 4 \u2013dependent recruitment of neutrophils to inflamed joints in mice with antigen\u2010induced arthritis","volume":"58","author":"Grespan","year":"2008","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.bcp.2020.114360_b0490","doi-asserted-by":"crossref","DOI":"10.1038\/srep13041","article-title":"Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model","volume":"5","author":"Seri","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114360_b0495","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-016-1055-2","article-title":"Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice","volume":"17","author":"Suzuki","year":"2016","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bcp.2020.114360_b0500","first-page":"1594","article-title":"Blocking Fc\u03b1 receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies","volume":"189","author":"van der Steen","year":"2012","journal-title":"J.I."},{"key":"10.1016\/j.bcp.2020.114360_b0505","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114360_b0510","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2020.114360_b0515","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar4579","article-title":"Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility","volume":"16","author":"Sur Chowdhury","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2020.114360_b0520","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fimmu.2019.00553","article-title":"IgA and Fc\u03b1RI: pathological roles and therapeutic opportunities","volume":"10","author":"Breedveld","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0525","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.39142","article-title":"Reversal of arthritis by human monomeric IgA through the receptor-mediated SH2 domain-containing phosphatase 1 inhibitory pathway: antiinflammatory action of monomeric IgA in arthritis","volume":"67","author":"Rossato","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bcp.2020.114360_b0530","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11427-012-4301-3","article-title":"Establishment of a transgenic mouse model with liver-specific expression of secretory immunoglobulin D","volume":"55","author":"Wang","year":"2012","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.bcp.2020.114360_b0535","doi-asserted-by":"crossref","unstructured":"J. Zhang et al. Regulation of T Cell Activities in Rheumatoid Arthritis by the Novel Fusion Protein IgD-Fc-Ig Front. Immunol. 11 755 DOI:10.3389\/fimmu.2020.00755.s002.","DOI":"10.3389\/fimmu.2020.00755"},{"key":"10.1016\/j.bcp.2020.114360_b0540","doi-asserted-by":"crossref","unstructured":"Tamma, S. M. & Coico, R. F. IgD-receptor-positive human T lymphocytes. II. Identification and partial characterization of human IgD-binding factor. Journal of immunology (Baltimore, Md. : 1950) 148, 2050-2057 (1992).","DOI":"10.4049\/jimmunol.148.7.2050"},{"key":"10.1016\/j.bcp.2020.114360_b0545","doi-asserted-by":"crossref","unstructured":"R.F. Coico, S.L. Tamma, M. Bessler, C.F. Wei, G.J. Thorbecke. IgD-receptor-positive human T lymphocytes. I. Modulation of receptor expression by oligomeric IgD and lymphokines. Journal of immunology (Baltimore, Md. : 1950) 145, 3556-3561 (1990).","DOI":"10.4049\/jimmunol.145.11.3556"},{"key":"10.1016\/j.bcp.2020.114360_b0550","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/cimm.1993.1301","article-title":"Regulation of IgD-receptor expression on murine T cells","volume":"152","author":"Swenson","year":"1993","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0555","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-065X.1988.tb00765.x","article-title":"Role of IgD and Tdelta cells in the regulation of the humoral immune response","volume":"105","author":"Coico","year":"1988","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bcp.2020.114360_b0560","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2366::AID-IMMU2366>3.0.CO;2-D","article-title":"Human T cell IgD receptors react with O-glycans on both human IgD and IgA1","volume":"28","author":"Swenson","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0565","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10238-009-0056-y","article-title":"Abnormal IgD and IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"9","author":"de Wolff","year":"2009","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bcp.2020.114360_b0570","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1073\/pnas.88.20.9238","article-title":"Specificity of the murine IgD receptor on T cells is for N-linked glycans on IgD molecules.","volume":"88","author":"Amin","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2020.114360_b0575","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1073\/pnas.88.20.9233","article-title":"IgD receptors on murine T-helper cells bind to Fd and Fc regions of immunoglobulin D.","volume":"88","author":"Tamma","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2020.114360_b0580","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/cimm.1998.1453","article-title":"Facilitated antigen presentation by B cells expressing IgD when responding T cells express IgD-receptors","volume":"192","author":"Wu","year":"1999","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0585","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0047-6374(97)01879-4","article-title":"The effect of aging on the immune response: influence of phosphatidylcholine-containing lipid on IgD-receptor expression and antibody formation","volume":"95","author":"Swenson","year":"1997","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bcp.2020.114360_b0590","doi-asserted-by":"crossref","first-page":"9179","DOI":"10.1073\/pnas.85.23.9179","article-title":"Release of IgD-binding factor by T cells under the influence of interleukin 2, interleukin 4, or cross-linked IgD.","volume":"85","author":"Amin","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2020.114360_b0595","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/cimm.1993.1302","article-title":"Regulation of IgD-receptor expression on murine T cells","volume":"152","author":"Amin","year":"1993","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0600","doi-asserted-by":"crossref","unstructured":"M. Iwashima, B.A. Irving, N.S. van Oers, A.C. Chan, A. Weiss. Pillars article: Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science. 1994. 263: 1136-1139. Journal of immunology (Baltimore, Md. : 1950) 193, 4279-4282 (2014).","DOI":"10.1093\/jimmunol\/193.9.4279"},{"key":"10.1016\/j.bcp.2020.114360_b0605","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.iy.11.040193.002315","article-title":"Regulation of lymphocyte function by protein phosphorylation","volume":"11","author":"Perlmutter","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0610","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(94)90334-4","article-title":"Signal transduction by lymphocyte antigen receptors","volume":"76","author":"Weiss","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2020.114360_b0615","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/cimm.2000.1747","article-title":"IgD receptor-mediated signal transduction in T cells","volume":"207","author":"Lakshmi Tamma","year":"2001","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0620","doi-asserted-by":"crossref","unstructured":"Y.-J. Wu et al. CP-25 Attenuates the Activation of CD4+ T Cells Stimulated with Immunoglobulin D in Human Front. Pharmacol. 9 4 DOI:10.3389\/fphar.2018.00004.s001.","DOI":"10.3389\/fphar.2018.00004.s001"},{"key":"10.1016\/j.bcp.2020.114360_b0625","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ni839","article-title":"A GPI-linked isoform of the IgD receptor regulates resting B cell activation","volume":"3","author":"Chaturvedi","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2020.114360_b0630","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41401-019-0337-2","article-title":"IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-\u03baB signaling pathways","volume":"41","author":"Han","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2020.114360_b0635","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1000500","article-title":"An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis","volume":"363","author":"Weinblatt","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2020.114360_b0640","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1002\/art.23992","article-title":"Treatment of rheumatoid arthritis with a syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial","volume":"58","author":"Weinblatt","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2020.114360_b0645","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4062\/biomolther.2019.153","article-title":"PBT-6, a Novel PI3KC2\u03b3 inhibitor in rheumatoid arthritis","volume":"28","author":"Kim","year":"2020","journal-title":"Biomol. Therap."},{"key":"10.1016\/j.bcp.2020.114360_b0650","first-page":"2888","article-title":"Efficacy and pharmacodynamic modeling of the BTK inhibitor evobrutinib in autoimmune disease models","volume":"202","author":"Haselmayer","year":"2019","journal-title":"J.I."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220305967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220305967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:25:23Z","timestamp":1757769923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220305967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":130,"alternative-id":["S0006295220305967"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114360","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114360"}}